Deletion mutants of virulence factors of pasteurellaceae
OwnerRobert E. Briggs, Fred M. Tatuminventors
Life of this patent
Estimating the term…
Abstract
Virulence factor mutants of Pasteurellaceae provide excellent safety and efficacy when used as vaccines in mammals, especially ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
Claims41
An isolated and purified bacterium of the family Pasteurellaceae comprising a mutant virulence factor, wherein said bacterium:
- a) expresses no biologically active form of the virulence factor;
- b) expresses an in-frame deletion form of the virulence factor which induces antibodies which specifically bind to virulence factor;
- and
- c) contains no foreign DNA.
A vaccine for reducing morbidity in a mammal, comprising:
- a bacterium of the family Pasteurellaceae comprising a mutant virulence factor,
- wherein the bacterium:
- a) expresses no biologically active form of the virulence factor,
- b) expresses a form of the virulence factor which induces antibodies which specifically bind to the virulence factor;
- and
- c) contains no foreign DNA;
- and
- a pharmaceutically or veterinarily acceptable carrier.
An isolated Pasteurellaceae virulence factor molecule which:
- a) contains an in-frame deletion:
- b) is biologically inactive;
- c) induces antibodies which specifically bind to virulence factor;
- and
- d) contains no foreign amino acid sequences.
Avaccine for reducing morbidity in a mammal, comprising:
- a Pasteurellaceae virulence factor protein which:
- a) is biologically inactive;
- b) induces antibodies which specifically bind to virulence factor;
- c) contains no foreign amino acid sequences;
- d) contains an in-frame deletion;
- and
- a pharmaceutically or veterinarily acceptable carrier.
Dependencies are inferred from the claim text.